Health After COVID-19 in the European Region Tyrol - South Tyrol
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 1,000
- Locations
- 1
- Primary Endpoint
- Predictors of recovery.
Study Overview
Brief Summary
The aim of the regional online questionnaire is to better understand the pattern of acute infection and the time of recovery of various symptoms.
Detailed Description
The ongoing COVID-19 pandemic considerably increases the demand for healthcare and raises concerns on longterm disease outcome. Accordingly, to increase the knowledge on recovery from symptoms of acute infection and longterm health effects, a regional COVID-19 online survey on the health-status after infection will be performed.
This cross-sectional anonymous online survey is initiated and conducted by an interdisciplinary study team of the Medical University of Innsbruck, Austria.
For each participant, demographic characteristics (e.g. age, gender, district affiliation, profession), medical history (presence of comorbidities, medication), diagnosis of COVID-19, symptoms and their duration, treatments and special conditions will be collected.
The aim of the survey is to better understand the pattern of acute infection and the time of recovery of various symptoms.
The anonymous online survey is open to individuals after COVID-19 infection (proven by SARS-Cov-2 positive PCR or antibody test) over the age of 16 and living in Tyrol (Western-Austria).
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 16 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •status post COVID-19 infection, defined by a positive SARS-Cov-2 PCR or antibody test
- •age ≥ 16years
- •resident in Tyrol (Austria)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Predictors of recovery.
Time Frame: up to 24 weeks
Identification of symptoms or comorbidities associated with Long-Covid-19.
Population based data on spectrum and recovery from COVID-19 symptoms
Time Frame: up to 24 weeks
Spectrum of symptoms at onset and at end of disease.
Secondary Outcomes
No secondary outcomes reported